495
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Evaluation of venous plasma glucose measured by point-of-care testing (Accu-Chek Inform II) and a hospital laboratory hexokinase method (Cobas c701) in oral glucose tolerance testing during pregnancy – a challenge in diagnostic accuracy

ORCID Icon, , , ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 607-614 | Received 03 Jun 2021, Accepted 09 Sep 2021, Published online: 24 Sep 2021

References

  • Claerhout H, De Prins M, Mesotten D, et al. Performance of strip-based glucose meters and cassette-based blood gas analyzer for monitoring glucose levels in a surgical intensive care setting. Clin Chem Lab Med.2016;54(1):169–180.
  • Coetzee A, Vyver M, Hoffmann M, et al. A comparison between point-of-care testing and venous glucose determination for the diagnosis of diabetes mellitus 6-12 weeks after gestational diabetes. Diabet Med. 2019;36(5):591–599.
  • Garcia-Claver A, Ramos-Corral R, Lavina-Fananas C, et al. Capillary glucose concentration during oral glucose tolerance test for the diagnosis of gestational diabetes. Int J Gynaecol Obstet. 2020;150(2):234–240.
  • Mitsios JV, Ashby LA, Haverstick DM, et al. Analytic evaluation of a new glucose meter system in 15 different critical care settings. J Diabetes Sci Technol. 2013;7(5):1282–1287.
  • Puntmann I, Wosniok W, Haeckel R. Comparison of several point-of-care testing (POCT) glucometers with an established laboratory procedure for the diagnosis of type 2 diabetes using the discordance rate. A new statistical approach.Clin Chem Lab Med.2003;41(6):809–820.
  • Floré KMJ, Fiers T, Delanghe JR. Critical evaluation of connectivity-based point of care testing systems of glucose in a hospital environment. Clin Chem Lab Med.2008;46(12):1763–1768.
  • Roche. Evaluation report: ACCU-CHEK® inform II test strips. [Internet]; 2013 [cited 2021 Jun 2]; Available from: https://diagnostics.roche.com/content/dam/diagnostics/us/en/products/a/accu-chek-inform-ii/toolkit/IMG-UPE-0613.pdf.
  • Equalis. Swedish national goals for measurement of glucose, guidance for the laboratory; 2018 [cited 2021 Jun 2. Available from: https://www.equalis.se/media/b2cj1rmk/pr008_eng_swedish-national-quality-goals-for-measurement-of-glucose_2018-12-10.pdf.
  • Nevander S, Landberg E, Blomberg M, et al. Comparison of venous and capillary sampling in oral glucose testing for the diagnosis of gestational diabetes mellitus: a diagnostic accuracy cross-sectional study using Accu-Chek inform II. Diagnostics. 2020;10(12):1011.
  • Pasqualetti S, Braga F, Panteghini M. Pre-analytical and analytical aspects affecting clinical reliability of plasma glucose results. Clin Biochem. 2017;50(10–11):587–594.
  • World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. WHO/NMH/MND/13.2 [Internet]; 2013 [cited 2021 Jun 2];[46]. Available from: https://apps.who.int/iris/bitstream/handle/10665/85975/WHO_NMH_MND_13.2_eng.pdf;jsessionid=24191948D212A22DB0DAC4981FAB5820?sequence=1.
  • Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.
  • Tieu J, McPhee AJ, Crowther CA, et al. Screening for gestational diabetes mellitus based on different risk profiles and settings for improving maternal and infant health. Cochrane Database Syst Rev. 2017;8:CD007222.
  • Dahlberg G. Statistical methods for medical and biological students.London: George Allen and Unwin; 1940.
  • Kristensen K, Wangel AM, Katsarou A, et al. Diagnosis of gestational diabetes mellitus with point-of-Care methods for glucose versus hospital laboratory method using isotope dilution gas Chromatography-Mass spectrometry as reference. J Diabetes Res.2020;2020(Mar 20):1–10.
  • Jeong TD, Cho EJ, Ko DH, et al. Large-scale performance evaluation of Accu-Chek Inform II point-of-care glucose meters. Scand J Clin Lab Invest. 2016;76(8):657–663.
  • Bukve T, Sandberg S, Vie WS, et al. Commutability of a whole-blood external quality assessment material for point-of-care C-reactive protein, glucose, and hemoglobin testing. Clin Chem. 2019;65(6):791–797.
  • Wang Y, Plebani M, Sciacovelli L, et al. Commutability of external quality assessment materials for point-of-care glucose testing using the clinical and Laboratory Standards Institute and International Federation of Clinical Chemistry approaches. J Clin Lab Anal.2020;34(8):e23327.
  • Gambino R. Glucose harmonization: the role of accurate calibrators. Arch Pathol Lab Med. 2009;133(1):12.
  • Ricos C, Alvarez V, Cava F, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest. 1999;59(7):491–500.
  • White GH, Farrance I, AACB of Unceratinty and Measurement Working Group. Uncertainty of measurement in quantitative medical testing: a laboratory implementation guide. Clin Biochem Rev. 2004;25(4):S1–S24.
  • European Federation of Clinical Chemistry and Laboratory Medicin. EFLM biological variation database [Internet]; 2021 [cited 2021 Jun 2]. Available from: https://biologicalvariation.eu/search?q=glucose.
  • Coustan DR. Diagnosis of gestational diabetes. Scand J Clin Lab Invest Suppl. 2014;244(suppl 244):27–33.
  • Nesbitt GS, Smye M, Sheridan B, HAPO Study Cooperative Research Group, et al. Integration of local and Central laboratory functions in a worldwide multicentre study: experience from the hyperglycemia and adverse pregnancy outcome (HAPO) study. Clin Trials. 2006;3(4):397–407.
  • Uchida K, Matuse R, Toyoda E, et al. A new method of inhibiting glycolysis in blood samples. Clin Chim Acta.1988;172(1):101–108.
  • Gambino R, Piscitelli J, Ackattupathil TA, et al. Acidification of blood is superior to sodium fluoride alone as an inhibitor of glycolysis. Clin Chem. 2009;55(5):1019–1021.
  • Bruns DE, Knowler WC. Stabilization of glucose in blood samples: why it matters. Clin Chem. 2009;55(5):850–852.
  • Chan AY, Swaminathan R, Cockram CS. Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem. 1989;35(2):315–317.
  • Sacks DB, Arnold M, Bakris GL, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2011;57(6):e1–e47.
  • Bonetti G, Giavarina D, Carta M. Clinical impact of citrate-containing tubes on the detection of glucose abnormalities by the oral glucose tolerance test. Diagnosis.2019;6(4):377–383.
  • Daly N, Flynn I, Carroll C, et al. Comparison of citrate-fluoride-EDTA with fluoride-EDTA additives to stabilize plasma glucose measurements in women being screened during pregnancy with an oral glucose tolerance test: a prospective observational study. Clin Chem. 2016;62(6):886–887.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.